Your browser doesn't support javascript.
loading
The IPSS-R has prognostic impact in untreated patients with MDS del(5q).
Kaivers, J; Lauseker, M; Hildebrandt, B; Fenaux, P; Pfeilstöcker, M; Valent, P; Platzbecker, U; Latagliata, R; Oliva, E N; Xicoy, B; Götze, K; Ganster, C; Haase, D; Bug, G; Kündgen, A; Gattermann, N; Haas, R; Germing, U.
Afiliación
  • Kaivers J; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Germany. Electronic address: jennifer.kaivers@med.uni-duesseldorf.de.
  • Lauseker M; Institute for Medical Informatics and Biometry, Ludwig-Maximilians-Universität, Munich, Germany.
  • Hildebrandt B; Department of Human Genetics, University Hospital Düsseldorf, Germany.
  • Fenaux P; Hôpital St. Louis, Université Paris 7, France.
  • Pfeilstöcker M; Hanusch-Krankenhaus Vienna and L. Boltzmann Cluster Oncology, Vienna, Austria.
  • Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna and L. Boltzmann Cluster Oncology, Vienna, Austria.
  • Platzbecker U; Department of Hematology and Oncology, University of Dresden, Germany.
  • Latagliata R; Policlinico Umberto I, Rome, Italy.
  • Oliva EN; Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy.
  • Xicoy B; Department of Hematology, Hospital Germans Trias i Pujol and Institut Català d'Oncologia-José Carreras Leukemia Research Institute, Badalona, Spain.
  • Götze K; Department of Hematology and Oncology, Technical University of Munich, Munich, Germany.
  • Ganster C; Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Germany.
  • Haase D; Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Germany.
  • Bug G; Department of Medicine, Hematology/Oncology, University Hospital, Frankfurt, Germany.
  • Kündgen A; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Germany.
  • Gattermann N; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Germany.
  • Haas R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Germany.
  • Germing U; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Germany.
Leuk Res ; 72: 27-33, 2018 09.
Article en En | MEDLINE | ID: mdl-30075323
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Cromosomas Humanos Par 5 / Deleción Cromosómica Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Cromosomas Humanos Par 5 / Deleción Cromosómica Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Año: 2018 Tipo del documento: Article